Organon & Co. (OGN)

US — Healthcare Sector
Peers: JNJ  BMY  ABBV  LLY  PFE  AMGN  MRK  GILD  SNY  AZN  NVS  BIIB 

Automate Your Wheel Strategy on OGN

With Tiblio's Option Bot, you can configure your own wheel strategy including OGN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol OGN
  • Rev/Share 24.4084
  • Book/Share 2.1019
  • PB 4.7005
  • Debt/Equity 16.524
  • CurrentRatio 1.6715
  • ROIC 0.1476

 

  • MktCap 2568365280.0
  • FreeCF/Share 2.5246
  • PFCF 3.9453
  • PE 3.3969
  • Debt/Assets 0.6808
  • DivYield 0.087
  • ROE 1.8171

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 3
  • DCF Score 5
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade OGN Evercore ISI Outperform In-line -- -- May 2, 2025
Downgrade OGN JP Morgan Neutral Underweight $18 $20 Sept. 6, 2024

News

OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit
OGN
Published: June 20, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , June 20, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the "Class Period"), of the important July 22, 2025 lead plaintiff deadline. So what: If you purchased Organon securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Read More
image for news OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
OGN
Published: June 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Organon & Co. (“Organon” or “the Company”) (NYSE: OGN) and certain of its officers.

Read More
image for news OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
OGN
Published: June 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

LOS ANGELES, June 20, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”).

Read More
image for news Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Faruqi & Faruqi Reminds Organon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025 - OGN
OGN
Published: June 20, 2025 by: PRNewsWire
Sentiment: Neutral

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Organon To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Organon between October 31, 2024 and April 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 20, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Organon & Co. ("Organon" or the …

Read More
image for news Faruqi & Faruqi Reminds Organon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025 - OGN
OGN COURT REMINDER: Organon & Co. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 22 Court Deadline (NYSE:OGN)
OGN
Published: June 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action.

Read More
image for news OGN COURT REMINDER: Organon & Co. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 22 Court Deadline (NYSE:OGN)
Levi & Korsinsky Reminds Organon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025 - OGN
OGN
Published: June 20, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , June 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Organon investors who were adversely affected by alleged securities fraud between October 31, 2024 and April 30, 2025.

Read More
image for news Levi & Korsinsky Reminds Organon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025 - OGN
Investors who lost money on Organon & Co.(OGN) should contact The Gross Law Firm about pending Class Action - OGN
OGN
Published: June 19, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , June 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

Read More
image for news Investors who lost money on Organon & Co.(OGN) should contact The Gross Law Firm about pending Class Action - OGN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming Deadlines - OGN
OGN
Published: June 18, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co.of Class Action Lawsuit and Upcoming Deadlines - OGN
July 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against OGN
OGN
Published: June 18, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).

Read More
image for news July 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against OGN
All You Need to Know About Organon (OGN) Rating Upgrade to Buy
OGN
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Positive

Organon (OGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Read More
image for news All You Need to Know About Organon (OGN) Rating Upgrade to Buy
OGN or DOCS: Which Is the Better Value Stock Right Now?
DOCS, OGN
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Neutral

Investors looking for stocks in the Medical Services sector might want to consider either Organon (OGN) or Doximity (DOCS). But which of these two stocks presents investors with the better value opportunity right now?

Read More
image for news OGN or DOCS: Which Is the Better Value Stock Right Now?
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN
OGN
Published: June 17, 2025 by: PRNewsWire
Sentiment: Neutral

NEW YORK , June 17, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGN
OGN SHAREHOLDER ALERT: BFA Law Reminds Organon & Co. Investors of Upcoming July 22 Class Action Deadline - Contact The Firm if You Suffered Losses
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE:OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action.

Read More
image for news OGN SHAREHOLDER ALERT: BFA Law Reminds Organon & Co. Investors of Upcoming July 22 Class Action Deadline - Contact The Firm if You Suffered Losses
Securities Class Action Lawsuit Filed Against Organon & Co. (OGN) - Levi & Korsinsky Represents Shareholders
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153350&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

Read More
image for news Securities Class Action Lawsuit Filed Against Organon & Co. (OGN) - Levi & Korsinsky Represents Shareholders
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / WHY: New York, N.Y., June 16, 2025.

Read More
image for news ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
Class Action Filed Against Organon & Co. (OGN) - July 22, 2025 Deadline to Join – Contact Levi & Korsinsky
OGN
Published: June 16, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.

Read More
image for news Class Action Filed Against Organon & Co. (OGN) - July 22, 2025 Deadline to Join – Contact Levi & Korsinsky
Join Class Action to Recover Losses from Organon & Co. (OGN) - Contact Levi & Korsinsky Before July 22, 2025
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153338&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq.

Read More
image for news Join Class Action to Recover Losses from Organon & Co. (OGN) - Contact Levi & Korsinsky Before July 22, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Organon & Co. of Class Action Lawsuit And Upcoming Deadlines - OGN
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. ("Organon" or the "Company") (NYSE:OGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Read More
image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Organon & Co. of Class Action Lawsuit And Upcoming Deadlines - OGN
Securities Fraud Class Action Filed Against Organon & Co. (OGN) - Levi & Korsinsky Reminds Investors of July 22, 2025
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153321&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

Read More
image for news Securities Fraud Class Action Filed Against Organon & Co. (OGN) - Levi & Korsinsky Reminds Investors of July 22, 2025
Organon & Co. (OGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
OGN
Published: June 16, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , June 16, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Organon & Co. ("Organon" or the "Company") (NYSE: OGN). IF YOU SUFFERED A LOSS ON YOUR ORGANON INVESTMENTS, CLICK HERE BEFORE JULY 22, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT What Is The Lawsuit About?

Read More
image for news Organon & Co. (OGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
OGN Shareholders Have the Right to Lead the Organon & Co. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - OGN
OGN
Published: June 16, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , June 16, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of the federal securities laws. Shareholders who purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 22, 2025.

Read More
image for news OGN Shareholders Have the Right to Lead the Organon & Co. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - OGN
Securities Lawsuit Alert: Organon & Co. (OGN) - Contact Levi & Korsinsky Before July 22, 2025
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153311&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

Read More
image for news Securities Lawsuit Alert: Organon & Co. (OGN) - Contact Levi & Korsinsky Before July 22, 2025
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm
OGN
Published: June 16, 2025 by: PRNewsWire
Sentiment: Neutral

LOS ANGELES , June 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Organon & Co. ("Organon" or "the Company") (NYSE: OGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 31, 2024 and April 30, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 22, 2025.

Read More
image for news OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN
Published: June 16, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153254&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN CLASS ACTION NOTICE: Organon & Co. was Sued for Securities Fraud; Contact BFA Law if You Suffered Losses
OGN
Published: June 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE:OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action.

Read More
image for news OGN CLASS ACTION NOTICE: Organon & Co. was Sued for Securities Fraud; Contact BFA Law if You Suffered Losses
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN
Published: June 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153058&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
Lost Money on Organon & Co. (OGN)? Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
OGN
Published: June 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153044&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq.

Read More
image for news Lost Money on Organon & Co. (OGN)? Join Class Action Before July 22, 2025 - Contact Levi & Korsinsky
Class Action Filed Against Organon & Co. (OGN) - July 22, 2025 Deadline to Join – Contact Levi & Korsinsky
OGN
Published: June 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.

Read More
image for news Class Action Filed Against Organon & Co. (OGN) - July 22, 2025 Deadline to Join – Contact Levi & Korsinsky
Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
OGN
Published: June 13, 2025 by: GlobeNewsWire
Sentiment: Neutral

LOS ANGELES, June 13, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming July 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) securities between October 31, 2024 to April 30, 2025, inclusive (the “Class Period”).

Read More
image for news Deadline Alert: Organon & Co. (OGN) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
Securities Lawsuit Alert: Organon & Co. (OGN) Investors - Contact Levi & Korsinsky Before July 22, 2025
OGN
Published: June 13, 2025 by: Accesswire
Sentiment: Neutral

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=153038&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq.

Read More
image for news Securities Lawsuit Alert: Organon & Co. (OGN) Investors - Contact Levi & Korsinsky Before July 22, 2025

About Organon & Co. (OGN)

  • IPO Date 2021-05-14
  • Website https://www.organon.com
  • Industry Drug Manufacturers - General
  • CEO Mr. Kevin Ali
  • Employees 10000

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio. It also offers cardiovascular products, consisting of several cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Rosuzet, and Zocor brands; Cozaar and Hyzaar for the treatment of hypertension; respiratory products for various treatments to control and prevent symptoms caused by asthma under the Singulair, Dulera, Zenhale, and Asmanex brand names; and Singulair, Nasonex, Clarinex, and Aerius for treating seasonal allergic rhinitis. In addition, the company provides dermatology products under the Diprosone and Elocon brand; bone health portfolio, including Fosamax brand name; non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brand names; Proscar for the treatment of symptomatic benign prostatic hyperplasia; and Propecia for the treatment of male pattern hair loss. The company sells its products primarily to drug wholesalers and retailers, hospitals, and government agencies, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was incorporated in 2020 and is based in Jersey City, New Jersey.